{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:47:11Z","timestamp":1724978831178},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,29]]},"DOI":"10.7759\/cureus.68127","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:08:15Z","timestamp":1724951295000},"source":"Crossref","is-referenced-by-count":0,"title":["Asymptomatic COVID-19 Infection-Induced Rhabdomyolysis in the Backdrop of Statin-Cyclosporine Drug Interaction"],"prefix":"10.7759","author":[{"given":"Vivek","family":"Nayak M","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FNU","family":"Bipasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotresha","family":"Neelakantappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2023.09.002","article-title":"COVID-19-associated rhabdomyolysis: a scoping review","volume":"136","author":"Preger A","year":"2023","unstructured":"Preger A, Wei R, Berg B, Golomb BA. COVID-19-associated rhabdomyolysis: a scoping review. Int J Infect Dis. 2023, 136:115-26.","journal-title":"Int J Infect Dis"},{"key":"ref2","article-title":"Rhabdomyolysis","author":"Stanley M","year":"2024","unstructured":"Stanley M, Chippa V, Aeddula NR, Rodriguez BSQ, Adigun R. Rhabdomyolysis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2006.09.020","article-title":"The syndrome of rhabdomyolysis: pathophysiology and diagnosis","volume":"18","author":"Giannoglou GD","year":"2007","unstructured":"Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Intern Med. 2007, 18:90-100. 10.1016\/j.ejim.2006.09.020","journal-title":"Eur J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-010-0104-3","article-title":"Drug-related myopathies of which the clinician should be aware","volume":"12","author":"Valiyil R","year":"2010","unstructured":"Valiyil R, Christopher-Stine L. Drug-related myopathies of which the clinician should be aware. Curr Rheumatol Rep. 2010, 12:213-20. 10.1007\/s11926-010-0104-3","journal-title":"Curr Rheumatol Rep"},{"key":"ref5","article-title":"rhabdomyolysis: a review of the literature","volume":"67","author":"Khan FY","year":"2009","unstructured":"Khan FY. rhabdomyolysis: a review of the literature. Neth J Med. 2009, 67:272-83.","journal-title":"Neth J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/v14102255","article-title":"Rhabdomyolysis after COVID-19 infection: a case report and review of the literature","volume":"14","author":"Bawor M","year":"2022","unstructured":"Bawor M, Sairam S, Rozewicz R, Viegas S, Comninos AN, Abbara A. Rhabdomyolysis after COVID-19 infection: a case report and review of the literature. Viruses. 2022, 14:2255. 10.3390\/v14102255","journal-title":"Viruses"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002853","article-title":"Rhabdomyolysis and acute kidney injury as leading COVID-19 presentation in an adolescent","volume":"39","author":"Tram N","year":"2020","unstructured":"Tram N, Chiodini B, Montesinos I, et al.. Rhabdomyolysis and acute kidney injury as leading COVID-19 presentation in an adolescent. Pediatr Infect Dis J. 2020, 39:314-5. 10.1097\/INF.0000000000002853","journal-title":"Pediatr Infect Dis J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-019273","article-title":"Rhabdomyolysis as the initial presentation of SARS-CoV-2 in an adolescent","volume":"147","author":"Gilpin S","year":"2021","unstructured":"Gilpin S, Byers M, Byrd A, Cull J, Peterson D, Thomas B, Jacobson P. Rhabdomyolysis as the initial presentation of SARS-CoV-2 in an adolescent. Pediatrics. 2021, 147:2020019273. 10.1542\/peds.2020-019273","journal-title":"Pediatrics"},{"key":"ref9","article-title":"Myoglobinuria","author":"Anwar MY","year":"2024","unstructured":"Anwar MY, Gupta V. Myoglobinuria. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2014.05.005","article-title":"Rhabdomyolysis: review of the literature","volume":"24","author":"Zutt R","year":"2014","unstructured":"Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJA, de Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord. 2014, 24:651-9.","journal-title":"Neuromuscul Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.09.026","article-title":"Molecular mechanisms of rhabdomyolysis-induced kidney injury: from bench to bedside","volume":"8","author":"Hebert JF","year":"2023","unstructured":"Hebert JF, Burfeind KG, Malinoski D, Hutchens MP. Molecular mechanisms of rhabdomyolysis-induced kidney injury: from bench to bedside. Kidney Int Rep. 2023, 8:17-29. 10.1016\/j.ekir.2022.09.026","journal-title":"Kidney Int Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103304","article-title":"Statin induced myopathy among patients attending the National Center for Diabetes, Endocrinology, and Genetics","volume":"74","author":"Abed W","year":"2022","unstructured":"Abed W, Abujbara M, Batieha A, Ajlouni K. Statin induced myopathy among patients attending the National Center for Diabetes, Endocrinology, and Genetics. Ann Med Surg (Lond). 2022, 74:103304. 10.1016\/j.amsu.2022.103304","journal-title":"Ann Med Surg (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19039","article-title":"Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine","volume":"33","author":"Maltz HC","year":"1999","unstructured":"Maltz HC, Balog DL, Cheigh JS. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine. Ann Pharmacother. 1999, 33:1176-9. 10.1345\/aph.19039","journal-title":"Ann Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.926064","article-title":"Suspected levetiracetam-induced rhabdomyolysis: a case report and literature review","volume":"21","author":"Moinuddin IA","year":"2020","unstructured":"Moinuddin IA. Suspected levetiracetam-induced rhabdomyolysis: a case report and literature review. Am J Case Rep. 2020, 21:926064. 10.12659\/AJCR.926064","journal-title":"Am J Case Rep"},{"key":"ref15","article-title":"Levetiracetam-induced rhabdomyolysis: a case report and literature review","volume":"22","author":"Kubota K","year":"2017","unstructured":"Kubota K, Yamamoto T, Kawamoto M, Kawamoto N, Fukao T. Levetiracetam-induced rhabdomyolysis: a case report and literature review. Neurol Asia. 2017, 22:275-8.","journal-title":"Neurol Asia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12659\/ajcr.904691","article-title":"Rhabdomyolysis in a patient with severe hypothyroidism","volume":"18","author":"Salehi N","year":"2017","unstructured":"Salehi N, Agoston E, Munir I, Thompson GJ. Rhabdomyolysis in a patient with severe hypothyroidism. Am J Case Rep. 2017, 18:912-8. 10.12659\/ajcr.904691","journal-title":"Am J Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0897190013516509","article-title":"Antipsychotic use and the risk of rhabdomyolysis","volume":"27","author":"Packard K","year":"2014","unstructured":"Packard K, Price P, Hanson A. Antipsychotic use and the risk of rhabdomyolysis. J Pharm Pract. 2014, 27:501-12. 10.1177\/0897190013516509","journal-title":"J Pharm Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2478\/jccm-2020-0032","article-title":"Rhabdomyolysis-induced acute renal injury in a schizophrenic patient","volume":"6","author":"Tiglis M","year":"2020","unstructured":"Tiglis M, Hurmuzache T, Bologa C, Neagu TP, Mirea L, Grintescu IM. Rhabdomyolysis-induced acute renal injury in a schizophrenic patient. J Crit Care Med (Targu Mures). 2020, 6:249-52. 10.2478\/jccm-2020-0032","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.34172\/aim.2023.08","article-title":"Aripiprazole-associated rhabdomyolysis in a 17-year-old male","volume":"26","author":"Kutlu A","year":"2023","unstructured":"Kutlu A, Song\u00fcr \u00c7Y, Apa H. Aripiprazole-associated rhabdomyolysis in a 17-year-old male. Arch Iran Med. 2023, 26:50-3. 10.34172\/aim.2023.08","journal-title":"Arch Iran Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000614","article-title":"Risperidone-associated rhabdomyolysis without neuroleptic malignant syndrome: a case report","volume":"37","author":"Look ML","year":"2017","unstructured":"Look ML, Boo YL, Chin PW, Hoo FK. Risperidone-associated rhabdomyolysis without neuroleptic malignant syndrome: a case report. J Clin Psychopharmacol. 2017, 37:105-6. 10.1097\/JCP.0000000000000614","journal-title":"J Clin Psychopharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271764-asymptomatic-covid-19-infection-induced-rhabdomyolysis-in-the-backdrop-of-statin-cyclosporine-drug-interaction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:08:21Z","timestamp":1724951301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271764-asymptomatic-covid-19-infection-induced-rhabdomyolysis-in-the-backdrop-of-statin-cyclosporine-drug-interaction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.68127","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}